相关实验视频
Updated: Jun 15, 2026
07:06
Metabolic Analysis of Drosophila melanogaster Larval and Adult Brains
Published on: August 7, 2018
9.3K
在COVID-19患者中使用代谢生物标志物识别明显的表型并改善预后
Andressa Santana1, Gabriele da Silveira Prestes1, Marinara Dagostin da Silva1
1Laboratory of Experimental Pathophysiology, Posgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense - Criciúma (SC), Brazil.
Critical care science
|August 7, 2024
概括
这项研究发现,虽然皮质醇单独预测住院COVID-19患者的死亡率,但添加代谢生物标志物可以提高预测的准确性. 这些生物标志物还显示出基于疾病严重程度的不同模式.
科学领域:
- 内分泌学 在内分泌学.
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- COVID-19是一种严重的呼吸道疾病,具有显著的系统性影响.
- 内分泌生物标志物,包括阿迪波金,可能在疾病的严重程度和结果中发挥作用.
- 了解这些关系可以改善患者的管理和预后.
研究的目的:
- 为了检查adipokines和其他内分泌生物标志物与住院COVID-19患者患者的患者结果之间的关联.
- 确定这些生物标志物的疾病严重程度和住院死亡率的预测价值.
- 探索基于生物标志物概况的潜在患者聚类.
主要方法:
- 对213名患有COVID-19的重症监护病房患者进行前性研究.
- 测量皮质醇,C-,葡萄糖类-1,胰岛素,YY, ghrelin,勒和抵抗蛋白.
- 对生物标志物对患者聚类,疾病严重程度和死亡率预测的贡献的分析.
主要成果:
- 皮质醇,抵抗素,瘦素,胰岛素和胆固醇水平在COVID-19严重程度组之间有显著差异.
- 较低的格林和较高的皮质醇水平与死亡率的增加有关.
- 将生物标志物与临床预测因素结合起来,提高了死亡率预测的准确性.
- 确定了两种不同的生物标志物表型,与疾病严重程度有关,但与死亡率无关.
结论:
- 皮质醇是唯一独立与COVID-19死亡率相关的单一生物标志物.
- 代谢生物标志物,当与临床参数相结合时,可以改善死亡率预测.
- 生物标志物表型与COVID-19的严重程度相关,但与死亡率没有直接关联.
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...